Trial Profile
A trial of AZP 2006 in healthy volunteers after repeated administration
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 04 Nov 2015
Price :
$35
*
At a glance
- Drugs Ezeprogind (Primary)
- Indications Alzheimer's disease; Dementia; Progressive supranuclear palsy
- Focus Adverse reactions
- 04 Nov 2015 New trial record